Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Cerilliant
Fish and Richardson
Medtronic
Express Scripts
Healthtrust
UBS
Julphar
AstraZeneca

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021046

« Back to Dashboard

NDA 021046 describes CELEXA, which is a drug marketed by Forest Labs and Allergan Sales Llc and is included in two NDAs. It is available from one supplier. Additional details are available on the CELEXA profile page.

The generic ingredient in CELEXA is citalopram hydrobromide. There are fifty-six drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the citalopram hydrobromide profile page.
Summary for 021046
Tradename:CELEXA
Applicant:Forest Labs
Ingredient:citalopram hydrobromide
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 021046

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;ORALStrengthEQ 10MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Dec 22, 1999TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Cerilliant
McKinsey
Citi
McKesson
Fuji
Teva
Julphar
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.